D.E. Shaw & Co’s FibroGen FGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-407
Closed -$9.09K 3252
2024
Q2
$9.09K Sell
407
-3,592
-90% -$80.2K ﹤0.01% 3040
2024
Q1
$235K Sell
3,999
-70,969
-95% -$4.17M ﹤0.01% 2699
2023
Q4
$1.66M Buy
74,968
+45,990
+159% +$1.02M ﹤0.01% 1837
2023
Q3
$625K Buy
28,978
+27,625
+2,042% +$596K ﹤0.01% 2242
2023
Q2
$91.3K Buy
1,353
+949
+235% +$64.1K ﹤0.01% 2701
2023
Q1
$188K Buy
+404
New +$188K ﹤0.01% 2817
2022
Q4
Sell
-506
Closed -$165K 3652
2022
Q3
$165K Buy
+506
New +$165K ﹤0.01% 3250
2021
Q3
Sell
-2,732
Closed -$1.82M 3688
2021
Q2
$1.82M Buy
+2,732
New +$1.82M ﹤0.01% 2142
2020
Q4
Sell
-1,039
Closed -$1.07M 2768
2020
Q3
$1.07M Sell
1,039
-1,690
-62% -$1.74M ﹤0.01% 1866
2020
Q2
$2.77M Buy
+2,729
New +$2.77M ﹤0.01% 1450
2020
Q1
Sell
-654
Closed -$701K 2717
2019
Q4
$701K Sell
654
-217
-25% -$233K ﹤0.01% 2065
2019
Q3
$805K Buy
871
+259
+42% +$239K ﹤0.01% 1919
2019
Q2
$691K Buy
+612
New +$691K ﹤0.01% 2023
2019
Q1
Sell
-6,547
Closed -$7.58M 2597
2018
Q4
$7.58M Buy
6,547
+6,295
+2,498% +$7.28M 0.01% 933
2018
Q3
$382K Buy
+252
New +$382K ﹤0.01% 2179
2017
Q4
Sell
-954
Closed -$1.28M 2548
2017
Q3
$1.28M Sell
954
-104
-10% -$140K ﹤0.01% 1684
2017
Q2
$854K Sell
1,058
-313
-23% -$253K ﹤0.01% 1789
2017
Q1
$845K Sell
1,371
-1,942
-59% -$1.2M ﹤0.01% 1775
2016
Q4
$1.77M Buy
3,313
+476
+17% +$255K ﹤0.01% 1483
2016
Q3
$1.47M Sell
2,837
-655
-19% -$339K ﹤0.01% 1528
2016
Q2
$1.43M Sell
3,492
-959
-22% -$393K ﹤0.01% 1609
2016
Q1
$2.37M Sell
4,451
-5,365
-55% -$2.86M ﹤0.01% 1311
2015
Q4
$7.48M Buy
9,816
+2,115
+27% +$1.61M 0.01% 771
2015
Q3
$4.22M Buy
7,701
+1,172
+18% +$642K 0.01% 1008
2015
Q2
$3.84M Buy
+6,529
New +$3.84M 0.01% 1148
2015
Q1
Sell
-659
Closed -$450K 2562
2014
Q4
$450K Buy
+659
New +$450K ﹤0.01% 2046